Repeat corneal transplantation in Southern China: Indications, surgical technique, outcomes, and risk factors for repeat keratoplasty failure

医学 外科 角膜移植 移植 眼科
作者
Qi Zheng,Qinxiang Zheng,Wuhe Chen,Jinyang Li,Zelin Zhao,Haiou Wang,Dan Jiang,Wei Chen
出处
期刊:Indian Journal of Ophthalmology [Medknow Publications]
卷期号:72 (Suppl 3): S482-S487
标识
DOI:10.4103/ijo.ijo_3333_23
摘要

Purpose: To report the indications, surgical techniques, and outcomes of repeat keratoplasty and evaluate the risk factors for graft failure in the Chinese population. Methods: The medical records of 216 patients (243 cases) who underwent at least two keratoplasties at a leading eye hospital in southern China between 2011 and 2020 were retrospectively reviewed. Indications and surgical procedures for repeat corneal transplantation were analyzed. Kaplan–Meier survival analysis was used to determine the graft survival rate after repeat keratoplasty. A multivariable survival model was used to assess the risk factors. Results: Repeated keratoplasties increased continuously from 2011 to 2020 ( P = 0.002). The most common primary indication was infectious keratitis (38.7%), and the most common reason for repeat keratoplasty was graft rejection (30.04%). Regraft techniques included penetrating keratoplasty (PK) in 165 cases (67.9%), deep lamellar keratoplasty (DALK) in 52 cases (21.40%), and endothelial keratoplasty (EK) in 26 cases (10.7%). Median survival was 5.3, 6.8, and 6.4 years for PK, DALK, and EK, respectively. The 5-year survival rate was 53.5%, 66.6%, and 69.8% for PK, DALK, and EK, respectively. The median LogMAR visual acuity was 1.4 for PK, 0.75 for DALK, and 1.2 for EK at the end of the follow-up. Multivariate analysis revealed that graft rejection is a risk factor for repeat keratoplasty failure ( P = 0.002). Conclusions: DALK and EK may provide better outcomes than PK in treating graft failure. Preventing and treating postoperative graft rejection may be key to improving regraft survival. These findings will aid in the management of failed corneal grafts.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
研友_n0kjPL完成签到,获得积分0
刚刚
1秒前
快乐的元正完成签到 ,获得积分10
3秒前
孤独的从彤完成签到 ,获得积分10
4秒前
千陽完成签到 ,获得积分10
7秒前
liaoyoujiao发布了新的文献求助10
8秒前
夜休2024完成签到 ,获得积分10
8秒前
9秒前
可绪kk完成签到 ,获得积分10
10秒前
陶军辉完成签到 ,获得积分10
11秒前
Skywalk满天星完成签到,获得积分10
13秒前
隐形白开水完成签到,获得积分0
16秒前
17秒前
jh完成签到 ,获得积分10
18秒前
liaoyoujiao完成签到,获得积分10
19秒前
19秒前
伍小南完成签到,获得积分10
21秒前
量子星尘发布了新的文献求助10
21秒前
22秒前
明亮谷波完成签到,获得积分10
22秒前
QAQ小白完成签到,获得积分10
22秒前
二三完成签到 ,获得积分10
23秒前
安安的小板栗完成签到,获得积分10
23秒前
juliar完成签到 ,获得积分10
24秒前
24秒前
hkunyu完成签到 ,获得积分10
25秒前
清风完成签到 ,获得积分10
28秒前
昏睡的天寿完成签到,获得积分10
28秒前
34秒前
考槃在涧完成签到 ,获得积分10
34秒前
阳光的音响完成签到 ,获得积分10
37秒前
简单若风完成签到,获得积分10
39秒前
Ch_7发布了新的文献求助10
39秒前
FUNG完成签到 ,获得积分10
40秒前
拾一完成签到,获得积分10
40秒前
川川完成签到 ,获得积分10
41秒前
库凯伊完成签到,获得积分10
41秒前
简单若风发布了新的文献求助10
42秒前
w0304hf完成签到,获得积分10
42秒前
谢谢你完成签到 ,获得积分10
43秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Encyclopedia of Agriculture and Food Systems Third Edition 2000
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 临床微生物学程序手册,多卷,第5版 2000
人脑智能与人工智能 1000
King Tyrant 720
Silicon in Organic, Organometallic, and Polymer Chemistry 500
Principles of Plasma Discharges and Materials Processing, 3rd Edition 400
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5599922
求助须知:如何正确求助?哪些是违规求助? 4685747
关于积分的说明 14838974
捐赠科研通 4674097
什么是DOI,文献DOI怎么找? 2538431
邀请新用户注册赠送积分活动 1505597
关于科研通互助平台的介绍 1471086